Sort
23,748 grants matching “melanoma”
Strategies for Cancer Immunotherapy Clinical Trials
$584,740Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Towards True Precision Oncology: Validation of a Comprehensively Humanized, Autologous Mouse Model
$584,722Ryan C Fields · Washington University · R01 · FY2019 · CA
Elucidation of novel anti-angiogenic therapies for the prevention and treatment of neovascular glaucoma
$584,568Silvia V Montaner · University Of Maryland Baltimore · R01 · FY2024 · EY
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
$584,415Isabelle Caroline Le Poole · Northwestern University At Chicago · R01 · FY2024 · HL
Applying pathomics to establish a biosignature for aggressive skin melanoma
$584,380Yvonne Margaret Saenger · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors
$584,339Ravindra K Pandey · Roswell Park Cancer Institute Corp · R01 · FY2010 · CA
MULTIDIMENSIONAL REVERSAL OF T-CELL EXHAUSTION IN MELANOMA
$584,200Sanford Burnham Prebys Medical Discovery Institute · · FY2020 · Department of the Army
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer
$584,177Andrew Y Koh · Ut Southwestern Medical Center · R01 · FY2022 · CA
A personalized approach to skin cancer prevention among adolescents
$584,156Yelena Ping Wu · University Of Utah · R01 · FY2023 · CA
Discovery of Small Molecule Ligands for PHD1 Reader Domain of Histone Demethylase KDM5A
$584,086Danica Galonic Fujimori · University Of California, San Francisco · R01 · FY2020 · CA
Discovery of Somatic Noncoding Variants that Serve as Drivers in Pediatric Cancers
$583,990Jinghui Zhang · St. Jude Children'S Research Hospital · R01 · FY2018 · CA
THE GENETICS OF OCULAR MELANOMA
$583,962Anne Mary Bowcock · Washington University · R01 · FY2012 · CA
Project 1: Multi-scale modeling of adaptive drug resistance in BRAF-mutant melanoma
$583,801Peter Karl Sorger · Harvard Medical School · U54 · FY2018 · CA
Dissecting the role of hypoxia in T cell differentiation in cancer
$583,740Greg M. Delgoffe · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
The Antigen Targeting Core
$583,628Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
$583,603Elad Ziv · University Of California, San Francisco · R01 · FY2022 · CA
Spectrum of clinical phenotype of the BAP1-tumor predisposition syndrome (BAP1-TPDS)
$583,603Mohamed H. Abdel-Rahman · Ohio State University · R01 · FY2024 · CA
Sustainability of the Go Sun Smart Program in a Recreation Industry
$583,392Barbara Walkosz · Klein Buendel, Inc. · R01 · FY2012 · CA
Low Dose Interleukin-2 for Regulatory T cell Modulation and the Treatment of CrohnâÂÂs Disease
$583,336Scott B Snapper · Boston Children'S Hospital · R01 · FY2024 · DK
Disclosing Genomic Incidental Findings in a Cancer Biobank: An ELSI Experiment
$583,293Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2014 · CA
Induction of autosis to overcome resistance in adoptive cell therapy for solid tumors
$583,266Yong Lu · Methodist Hospital Research Institute · R01 · FY2023 · CA
Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology.
$583,253Nicole Franziska Steinmetz · University Of California, San Diego · U01 · FY2021 · CA
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds
$583,253Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2019 · CA
Functional assessment of genes and common genetic risk variants in ovarian cancer
$583,252Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2010 · CA
TARGETED RADIOTHERAPY FOR MELANOMA; HERBERT MOORE, PI
$583,200Alphamed Incorporated · · FY2012 · Department of Energy